Investigación
Educación
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Biology
Matthew Trendowski has not added Biography.
If you are Matthew Trendowski and would like to personalize this page please email our Author Liaison for assistance.
The promise of sonodynamic therapy.
Cancer metastasis reviews Mar, 2014 | Pubmed ID: 24346159
The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.
Anticancer research May, 2014 | Pubmed ID: 24778021
The rhetoric of cancer.
Cancer causes & control : CCC Oct, 2014 | Pubmed ID: 25011402
Exploiting the cytoskeletal filaments of neoplastic cells to potentiate a novel therapeutic approach.
Biochimica et biophysica acta Dec, 2014 | Pubmed ID: 25286320
Using cytochalasins to improve current chemotherapeutic approaches.
Anti-cancer agents in medicinal chemistry , 2015 | Pubmed ID: 25322987
Tolerated doses in zebrafish of cytochalasins and jasplakinolide for comparison with tolerated doses in mice in the evaluation of pre-clinical activity of microfilament-directed agents in tumor model systems in vivo.
In vivo (Athens, Greece) Nov-Dec, 2014 | Pubmed ID: 25398795
Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents.
Anticancer research Jan, 2015 | Pubmed ID: 25550536
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration.
Investigational new drugs Apr, 2015 | Pubmed ID: 25560541
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
Investigational new drugs Apr, 2015 | Pubmed ID: 25563824
The inherent metastasis of leukaemia and its exploitation by sonodynamic therapy.
Critical reviews in oncology/hematology May, 2015 | Pubmed ID: 25604499
Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound.
Cancer letters May, 2015 | Pubmed ID: 25667120
Effects of alkylation and immunopotentiation against Ehrlich ascites murine carcinoma in vivo using novel tetra-O-acetate haloacetamido carbohydrate analogs.
European journal of medicinal chemistry Jun, 2015 | Pubmed ID: 26005028
Targeting the plasma membrane of neoplastic cells through alkylation: a novel approach to cancer chemotherapy.
Investigational new drugs Aug, 2015 | Pubmed ID: 26095786
PU-H71: An improvement on nature's solutions to oncogenic Hsp90 addiction.
Pharmacological research : the official journal of the Italian Pharmacological Society Jun, 2015 | Pubmed ID: 26117427
Syracuse University
Matthew Trendowski1,
Timothy D. Christen1,
Joseph N. Zoino1,
Christopher Acquafondata1,
Thomas P. Fondy1
1Department of Biology, Syracuse University
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados